These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18030063)

  • 1. Different effects of antiarrhythmic drugs on the rate-dependency of QT interval: a study with amiodarone and flecainide.
    Malfatto G; Zaza A; Facchini M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):535-40. PubMed ID: 18030063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.
    Husser D; Stridh M; Sornmo L; Geller C; Klein HU; Olsson SB; Bollmann A
    Am J Cardiol; 2005 Feb; 95(4):526-8. PubMed ID: 15695146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1995 Sep; 155(17):1885-91. PubMed ID: 7677555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation.
    John S; Salmas J; Kornej J; Löbe S; Stridh M; Sörnmo L; Hindricks G; Husser D; Bollmann A
    Int J Cardiol; 2013 Sep; 167(5):2354-6. PubMed ID: 23183245
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
    Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the non-linear rate-dependency of QT interval in humans.
    Malfatto G; Facchini M; Zaza A
    Europace; 2003 Apr; 5(2):163-70. PubMed ID: 12633641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo.
    Matsukura S; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    Cardiovasc Toxicol; 2017 Apr; 17(2):157-162. PubMed ID: 27040813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2011 Jan; 12(1):131-40. PubMed ID: 21126199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
    Osadchii OE
    Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: outpatient presentation and management.
    Ezekowitz MD; Aikens TH; Nagarakanti R; Shapiro T
    Circulation; 2011 Jul; 124(1):95-9. PubMed ID: 21730322
    [No Abstract]   [Full Text] [Related]  

  • 14. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
    Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
    Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiarrhythmic drugs on QT interval dispersion--relationship to antiarrhythmic action and proarrhythmia.
    Gillis AM
    Prog Cardiovasc Dis; 2000; 42(5):385-96. PubMed ID: 10768315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with acute atrial fibrillation in the ED.
    Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
    Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization.
    Houltz B; Darpö B; Swedberg K; Blomström P; Crijns HJ; Jensen SM; Svernhage E; Edvardsson N
    Europace; 2000 Jan; 2(1):20-31. PubMed ID: 11225593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best evidence topic report. Amiodarone or flecainide for cardioversion in acute onset atrial fibrillation.
    Argall J; Crawford I
    Emerg Med J; 2004 Mar; 21(2):199. PubMed ID: 14988348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.